Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Journal of Sun Yat-sen University(Medical Sciences) ; (6): 664-672, 2019.
Article in Chinese | WPRIM | ID: wpr-817694

ABSTRACT

@# 【Objective】To investigate the effects of Epstein-Barr virus(EBV)on proliferation,apoptosis and lipid metabolism of gastric cancer cells,revealing the pathogenesis and development of EBV-associated gastric carcinoma (EBVaGC).【Methods】EBV-positive cell line AGS-EBV was established by co-culturing AGS and Akata. Then we compared proliferation,apoptosis and lipid metabolism level between AGS and AGS-EBV cells. CCK-8 assays and Annexin V PE/7-AAD assays were performed to determine the proliferation and apoptosis of gastric cancer cells. Oil-Red O staining and three kinds of kits were used to detect lipid contents including lipid droplets,free fatty acid,triacylglycerol and total cholesterol. Key enzymes of lipogenesis were measured by qRT-PCR.【Results】EBV promoted the proliferation of gastric cancer cell line AGS(F = 23.214,P = 0.001;P values of 24 h,48 h,72 h,96 h and 120 h were 0.007, 0.004,<0.001,<0.001 and <0.001,respectively),inhibited apoptosis(P values of late and total apoptotic rates were 0.032,< 0.001),and increased intracellular lipid droplets,free fatty acids(P < 0.001),triacylglycerol(P = 0.004) and total cholesterol(P < 0.001)probably via lipogenesis. 【Conclusions】EBV promotes proliferation,inhibits apoptosis, and enhances lipid metabolism of gastric cancer cells.

2.
Chinese Journal of Cancer ; (12): 531-537, 2015.
Article in English | WPRIM | ID: wpr-349570

ABSTRACT

<p><b>INTRODUCTION</b>Brain metastasis is common in relapsed neuroblastoma patients, but the characteristics of brain metastasis remain largely unknown. This study aimed to investigate the status of brain metastasis with neuroblastoma in South China.</p><p><b>METHODS</b>In this retrospective case-based study, 106 patients with stage 4 neuroblastoma from the Department of Pediatric Oncology in Sun Yat-sen University Cancer Center between January 2004 and May 2013 were included. The incidence, risk factors, and survival status of these patients were reviewed and analyzed.</p><p><b>RESULTS</b>Of the 106 patients, 11 (10.4%) developed brain metastasis, accounting for 20.0% of 55 patients with relapse or progression. The age at initial diagnosis of the 11 patients ranged from 2 to 10 years (median 4 years), which was younger than that of the patients without brain metastasis (median 5 years, range 1-10 years, P=0.073). The male to female ratio of the 11 patients was 8:3, which was not significantly different from that of the patients without brain metastasis (P=0.86). Patients with brain metastasis had higher lactate dehydrogenase levels than those without brain metastasis, but the differences were not significant (P=0.076). Eight patients died, and 3 patients survived. The median interval from the initial diagnosis to the development of brain metastasis was 18 months (range 6-32 months). The median survival was 4 months (range 1 day to 29 months) after the diagnosis of brain metastasis. The median interval from the manifestation of brain metastasis to death was 3 months (range 1 day to 11 months).</p><p><b>CONCLUSIONS</b>High-risk factors for brain metastasis in cases of neuroblastoma include bone marrow involvement and a younger age at initial diagnosis. Nevertheless, multiple treatment modalities can improve disease-free survival.</p>


Subject(s)
Child , Female , Humans , Male , Age Factors , Antineoplastic Combined Chemotherapy Protocols , Brain , Brain Neoplasms , China , Disease Progression , Disease-Free Survival , Incidence , L-Lactate Dehydrogenase , Mortality , Neoplasm Metastasis , Neoplasm Recurrence, Local , Neuroblastoma , Retrospective Studies , Risk Factors
3.
Journal of Southern Medical University ; (12): 1331-1334, 2008.
Article in Chinese | WPRIM | ID: wpr-270148

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the adsorption and desorption of epirubicin (EADM) by carbon-coated iron nanocrystals (CCIN).</p><p><b>METHODS</b>EADM standard curve was generated. After thorough mixture of CCIN and EADM with sonication, the mixture solution was centrifuged at high speed to obtain dissociated EADM for evaluating the adsorption capacity of CCIN. A dialyzer was used to evaluate the desorption of drug-loaded CCIN particles in different media (PBS, normal saline, or distilled water), at different temperatures, and with different quantities of loaded drug.</p><p><b>RESULTS</b>The adsorption of EADM by CCIN presented linear adsorption before saturation and saturation adsorption, with an adsorption saturation point of about 160 microg/mg. The desorption of EADM from CCIN particles was affected by such factors as the extraction media, temperature, and quantity of the loaded drug. Compared to distilled water, PBS and normal saline improved the release rate of EADM from the drug-loaded CCIN particles. Higher temperature also contributed to higher release rate of EADM. Higher release rate of EADM occurred after the CCIN particles adsorbed greater amount of EADM.</p><p><b>CONCLUSION</b>CCIN shows an EADM adsorption pattern of Langmuir isotherm adsorption. Such factors as higher temperature, PBS solution, higher speed of medium replacement, and more drug adsorbed all contribute to a higher release rate of EADM.</p>


Subject(s)
Adsorption , Antibiotics, Antineoplastic , Chemistry , Pharmacokinetics , Carbon , Chemistry , Delayed-Action Preparations , Chemistry , Pharmacokinetics , Drug Carriers , Drug Delivery Systems , Epirubicin , Chemistry , Pharmacokinetics , Iron , Chemistry , Nanoparticles , Chemistry
SELECTION OF CITATIONS
SEARCH DETAIL